genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Merck & Co., Sanofi Shell Out $5.2B in Deals to Strengthen…
Extracellular Matrix
Mapping Single-Cell pH Levels Could Hold Key to Improved Cancer Treatments
Genetics
Engineered Probiotic Provides New Approach for Treating Inflammatory Bowel Disease
News
CRISPR’s Unwanted Edits Unmasked Using Faster Cell Free System
News
$70M from Sidney and Caroline Kimmel to Fund Thomas Jefferson U….
Insights
Bioprocessing
Insect Pupae May Transform Protein Production
Bioprocessing
Optimizing Biotherapeutic Onboarding
December 2019 Vol. 39 No. 12
CRISPR Vehicles Break Down Barriers to In Vivo Genome Editing
December 2019 Vol. 39 No. 12
For Whom the Perturbed Cell Signaling Pathway Tolls
December 2019 Vol. 39 No. 12
Metabolomics Technology Navigates Oceans of Data
A-Lists
Cancer
Top 10 Immuno-Oncology Startups of 2019
Drug Discovery
Top 10 Pharma Companies of 2019
December 2019 Vol. 39 No. 12
Top 25 Biotech Companies of 2019
Insights
Top 10 Asia Biopharma Clusters 2019
Brexit
Top 10 European Biopharma Clusters
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Merck & Co., Sanofi Shell Out $5.2B in Deals to Strengthen…
Extracellular Matrix
Mapping Single-Cell pH Levels Could Hold Key to Improved Cancer Treatments
Genetics
Engineered Probiotic Provides New Approach for Treating Inflammatory Bowel Disease
News
$70M from Sidney and Caroline Kimmel to Fund Thomas Jefferson U….
Magazine
All
Supplement
December 2019 Vol. 39 No. 12
CRISPR Vehicles Break Down Barriers to In Vivo Genome Editing
December 2019 Vol. 39 No. 12
For Whom the Perturbed Cell Signaling Pathway Tolls
December 2019 Vol. 39 No. 12
Metabolomics Technology Navigates Oceans of Data
December 2019 Vol. 39 No. 12
Taking Cell Lines to the Bank
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Upcoming Webinars
The Dynamic Microbiome
December 2019 Vol. 39 No. 12
Understanding and Overcoming the Immune Response from Synthetic mRNAs
December 2019 Vol. 39 No. 12
Accelerating AAV to the Clinic with Purification Improvements
December 2019 Vol. 39 No. 12
Evaluation of a Small-Scale Perfusion Mimic for Intensified Processes
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Companies
Audentes Therapeutics
Audentes Therapeutics
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Audentes Therapeutics
Astellas to Acquire Audentes for $3B, Seeing Gene Therapy as “Key Driver”
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS